XML 56 R42.htm IDEA: XBRL DOCUMENT
v3.25.1

Net Income Per Share Attributable to Common Stockholders (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):
| Fiscal Year Ended March 31,
| 2025 |  | 2024 |  | 2023
Numerator |  |  |  |  |
Net income | $ | 223,185 |  |  | $ | 147,582 |  |  | $ | 112,818 |
Denominator |  |  |  |  |
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic | 186,841 |  |  | 190,172 |  |  | 193,176 |
Dilutive effect of stock options | 13,021 |  |  | 15,346 |  |  | 20,027 |
Dilutive effect of common stock warrants | — |  |  | 72 |  |  | 139 |
Dilutive effect of other share-based awards | 1,346 |  |  | 144 |  |  | 83 |
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted | 201,208 |  |  | 205,734 |  |  | 213,425 |
Net income per share attributable to Class A and Class B common stockholders: |  |  |  |  |
Basic | $ | 1.19 |  |  | $ | 0.78 |  |  | $ | 0.58 |
Diluted | $ | 1.11 |  |  | $ | 0.72 |  |  | $ | 0.53 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):
| Fiscal Year Ended March 31,
| 2025 |  | 2024 |  | 2023
Other share-based awards | 102 |  |  | 883 |  |  | 572 |
Common stock warrants | 379 |  |  | 516 |  |  | 516 |
Total | 481 |  |  | 1,399 |  |  | 1,088 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration